𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Proteasome-mediated degradation of the C-terminus of the Alzheimer's disease β-amyloid protein precursor: Effect of C-terminal truncation on production of β-amyloid protein

✍ Scribed by Janelle Nunan; Nicholas A. Williamson; Andrew F. Hill; M. Fleur Sernee; Colin L. Masters; David H. Small


Publisher
John Wiley and Sons
Year
2003
Tongue
English
Weight
158 KB
Volume
74
Category
Article
ISSN
0360-4012

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

The β‐amyloid protein (Aβ) is derived by proteolytic processing of the amyloid protein precursor (APP). Cleavage of APP by β‐secretase generates a C‐terminal fragment (APP‐CTFβ), which is subsequently cleaved by γ‐secretase to produce Aβ. Our previous studies have shown that the proteasome can cleave the C‐terminal cytoplasmic domain of APP. To identify proteasome cleavage sites in APP, two peptides homologous to the C‐terminus of APP were incubated with recombinant 20S proteasome. Cleavage of the peptides was monitored by reversed phase high‐performance liquid chromatography and mass spectrometry. Proteasome cleaved the APP C‐terminal peptides at several sites, including a region around the sequence YENPTY that interacts with several APP‐binding proteins. To examine the effect of this cleavage on Aβ production, APP‐CTFβ and mutant forms of APP‐CTFβ terminating on either side of the YENPTY sequence were expressed in CHO cells. Truncation of APP‐CTFβ on the N‐terminal side of the YENPTY sequence at residue 677 significantly decreased the amount of Aβ produced, whereas truncation on the C‐terminal side of residue 690 had little effect. The results suggest that proteasomal cleavage of the cytosolic domain of APP at the YENPTY sequence decreases γ‐secretase processing, and consequently inhibits Aβ production. Therefore, the proteasome‐dependent trafficking pathway of APP may be a valid therapeutic target for altering Aβ production in the Alzheimer's disease brain. © 2003 Wiley‐Liss, Inc.


📜 SIMILAR VOLUMES


Cytoplasmic domain of the β-amyloid prot
✍ Megan L. Kerr; David H. Small 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 200 KB 👁 1 views

The ␤-amyloid protein precursor (APP) has been extensively studied for its role in amyloid production and the pathogenesis of Alzheimer's disease (AD). However, little is known about the normal function of APP and its biological interactions. In this Mini-Review, the role of the cytoplasmic domain o

Individual isoforms of the amyloid βprec
✍ Angela M. Gillian; Ian McFarlane; Frances M. Lucy; Caroline Overly; Lisa McConlo 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 118 KB 👁 1 views

The amyloid b precursor protein (AbPP) can exist as a membrane-bound glycoprotein which modulates neural cell adhesion. The adhesion of clones of the AtT20 mouse pituitary cell line, transfected with cDNA coding for the 695 (AbPP 695 ) and 751 (AbPP 751 ) amino acid forms of the protein, to individu

Alzheimer's disease and hereditary cereb
✍ Dr. William E. van Nostrand; Steven L. Wagner; Joost Haan; Egbert Bakker; Raymun 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 419 KB 👁 1 views

## Abstract The amyloid β‐protein is a 39‐42 amino acid peptide that is deposited in senile plaques and in cerebral vessel walls in individuals with Alzheimer's disease, Down's syndrome, hereditary cerebral hemorrhage with amyloidosis–Dutch type (HCHW A‐D), and, to a much lesser extent, normal agin